The Role of Mitochondrial Functional Proteins in ROS Production in Ischemic Heart Diseases

Oxidative Medicine and Cellular Longevity

Volumn 2016, Issue , 2016, Pages

  Pei, Haifeng ^a,b   Yang, Yi ^a   Zhao, Heng ^a   Li, Xiuchuan ^a   Yang, Dachun ^a   Li, De ^a   Yang, Yongjian ^a,b  

^a CHENGDU MILITARY GENERAL HOSPITAL   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLOGY; CELL DEATH; DISEASES; ELECTRON TRANSPORT PROPERTIES; PROTEINS;

ELECTRON TRANSPORT CHAIN; FUNCTIONAL PROTEINS; ISCHEMIC HEART DISEASE; MITOCHONDRIAL DYSFUNCTION; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; MITOCHONDRIAL PROTEIN; REACTIVE OXYGEN SPECIES; UNCOUPLING PROTEINS;

MITOCHONDRIA;

CONNEXIN 43; ELECTRON TRANSPORT CHAIN COMPLEX; MITOCHONDRIAL CALCIUM UNIPORTER; MITOCHONDRIAL CALCIUM UPTAKE 1; MITOCHONDRIAL CALCIUM UPTAKE 2; MITOCHONDRIAL DYNAMIC PROTEIN; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; MITOCHONDRIAL PROTEIN; REACTIVE OXYGEN METABOLITE; STAT3 PROTEIN; TRANSLOCASES OF OUTER MEMBRANE COMPLEX; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN;

DISORDERS OF MITOCHONDRIAL FUNCTIONS; HUMAN; ISCHEMIC HEART DISEASE; MYOCARDIAL DISEASE; NONHUMAN; PROTEIN FUNCTION; REVIEW; ANIMAL; BIOLOGICAL MODEL; ELECTRON TRANSPORT; HEART MUSCLE ISCHEMIA; METABOLISM; MITOCHONDRION;

ANIMALS; ELECTRON TRANSPORT; HUMANS; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; MODELS, BIOLOGICAL; MYOCARDIAL ISCHEMIA; REACTIVE OXYGEN SPECIES;

EID: 84971646051     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2016/5470457     Document Type: Review

References (98)

1. V. L. Roger, A. S. Go, D. M. Lloyd-Jones et al., "Executive summary: heart disease and stroke statistics-2012 update: A report from the American Heart Association, " Circulation, vol. 125, no. 1, pp. 188-197, 2012.
2. H. He, N. Li, Z. Zhao, F. Han, X. Wang, and Y. Zeng, "Ischemic postconditioning improves the expression of cellularmembrane connexin 43 and attenuates the reperfusion injury in rat acute myocardial infarction, " Biomedical Reports, vol. 3, pp. 668-674, 2015.
3. W. H. Townley-Tilson, X. Pi, and L. Xie, "The role of oxygen sensors, hydroxylases, and hif in cardiac function and disease, " Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 676893, 10 pages, 2015.
4. Z. W. Zhang, X. C. Xu, T. Liu, and S. Yuan, "Mitochondrionpermeable antioxidants to treat ROS-burst-mediated acute diseases, " Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 6859523, 10 pages, 2016.
5. E. Murphy and C. Steenbergen, "Preconditioning: The mitochondrial connection, " Annual Review of Physiology, vol. 69, pp. 51-67, 2007.
6. D. B. Zorov, C. R. Filburn, L.-O. Klotz, J. L. Zweier, and S. J. Sollott, "Reactive oxygen species (ROS)-induced ROS release: A new phenomenon accompanying induction of the mitochondrial permeability transition in cardiacmyocytes, "The Journal of Experimental Medicine, vol. 192, no. 7, pp. 1001-1014, 2000.
7. A. A. Knowlton, L. Chen, and Z. A. Malik, "Heart failure and mitochondrial dysfunction: The role of mitochondrial fission/fusion abnormalities and new therapeutic strategies, " Journal of Cardiovascular Pharmacology, vol. 63, no. 3, pp. 196-206, 2014.
8. F. J. Giordano, "Oxygen, oxidative stress, hypoxia, and heart failure, " The Journal of Clinical Investigation, vol. 115, no. 3, pp. 500-508, 2005.
9. C. Maack, E. R. Dabew, M. Hohl, H.-J. Schäfers, and M. Böhm, "Endogenous activation of mitochondrial KATP channels protects human failingmyocardiumfromhydroxyl radicalinduced stunning, " Circulation Research, vol. 105, no. 8, pp. 811-817, 2009.
10. F. G. Akar, M. A. Aon, G. F. Tomaselli, and B. O'Rourke, "The mitochondrial origin of postischemic arrhythmias, " The Journal of Clinical Investigation, vol. 115, no. 12, pp. 3527-3535, 2005.
11. K. Schwarz, N. Siddiqi, S. Singh, C. J. Neil, D. K. Dawson, and M. P. Frenneaux, "The breathing heart-mitochondrial respiratory chain dysfunction in cardiac disease, " International Journal of Cardiology, vol. 171, no. 2, pp. 134-143, 2014.
12. T. Ide, H. Tsutsui, S. Kinugawa et al., "Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium, " Circulation Research, vol. 85, no. 4, pp. 357-363, 1999.
13. E. Murphy and C. Steenbergen, "Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury, " Physiological Reviews, vol. 88, no. 2, pp. 581-609, 2008.
14. R. J. Scheubel, M. Tostlebe, A. Simm et al., "Dysfunction of mitochondrial respiratory chain complex I in human failing myocardiumis not due to disturbedmitochondrial gene expression, " Journal of theAmerican College of Cardiology, vol. 40, no. 12, pp. 2174-2181, 2002.
15. D. Jarreta, J. Orús, A. Barrientos et al., "Mitochondrial function in heartmuscle frompatients with idiopathic dilated cardiomyopathy, " Cardiovascular Research, vol. 45, no. 4, pp. 860-865, 2000.
16. E. Arbustini, M. Diegoli, R. Fasani et al., "Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy, " American Journal of Pathology, vol. 153, no. 5, pp. 1501-1510, 1998.
17. M. P. Murphy, "How mitochondria produce reactive oxygen species, " The Biochemical Journal, vol. 417, no. 1, pp. 1-13, 2009.
18. M. D. Brand, "The sites and topology ofmitochondrial superoxide production, " Experimental Gerontology, vol. 45, no. 7-8, pp. 466-472, 2010.
19. Q. Chen, A. K. S. Camara, D. F. Stowe, C. L. Hoppel, and E. J. Lesnefsky, "Modulation of electron transport protects cardiac mitochondria and decreases myocardial injury during ischemia and reperfusion, " American Journal of Physiology-Cell Physiology, vol. 292, no. 1, pp. C137-C147, 2007.
20. Q. Chen, C. L. Hoppel, and E. J. Lesnefsky, "Blockade of electron transport before cardiac ischemia with the reversible inhibitor amobarbital protects rat heart mitochondria, " The Journal of Pharmacology and ExperimentalTherapeutics, vol. 316, no. 1, pp. 200-207, 2006.
21. V. Yankovskaya, R. Horsefield, S. Törnroth et al., "Architecture of succinate dehydrogenase and reactive oxygen species generation, " Science, vol. 299, no. 5607, pp. 700-704, 2003.
22. T. M. Iverson, E. Maklashinas, and G. Cecchinis, "Structural basis for malfunction in complex II, " The Journal of Biological Chemistry, vol. 287, no. 42, pp. 35430-35438, 2012.
23. M. Aldakkak, D. F. Stowe, Q. Chen, E. J. Lesnefsky, and A. K. S. Camara, "Inhibited mitochondrial respiration by amobarbital during cardiac ischaemia improves redox state and reduces matrix Ca2+ overload and ROS release, " Cardiovascular Research, vol. 77, no. 2, pp. 406-415, 2008.
24. S. Shiva, M. N. Sack, J. J. Greer et al., "Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer, " The Journal of Experimental Medicine, vol. 204, no. 9, pp. 2089-2102, 2007.
25. S. M. Nadtochiy, L. S. Burwell, and P. S. Brookes, "Cardioprotection and mitochondrial S-nitrosation: effects of Snitroso-2-mercaptopropionyl glycine (SNO-MPG) in cardiac ischemia-reperfusion injury, " Journal of Molecular and Cellular Cardiology, vol. 42, no. 4, pp. 812-825, 2007.
26. F. Sam, D. L. Kerstetter, D. R. Pimental et al., "Increased reactive oxygen species production and functional alterations in antioxidant enzymes in human failing myocardium, " Journal of Cardiac Failure, vol. 11, no. 6, pp. 473-480, 2005.
27. J. L. Tarry-Adkins, H. L. Blackmore, M. S. Martin-Gronert et al., "Coenzyme Q10 prevents accelerated cardiac aging in a rat model of poor maternal nutrition and accelerated postnatal growth, "MolecularMetabolism, vol. 2, no. 4, pp. 480-490, 2013.
28. M. Bentinger, K. Brismar, and G. Dallner, "The antioxidant role of coenzymeQ, " Mitochondrion, vol. 7, supplement, pp. S41-S50, 2007.
29. C. Schmelzer, M. Kitano, K. Hosoe, and F. Döring, "Ubiquinol affects the expression of genes involved in PPAR signalling and lipid metabolism without changes in methylation of CpG promoter islands in the liver of mice, " Journal of Clinical Biochemistry and Nutrition, vol. 50, no. 2, pp. 119-126, 2012.
30. J. J. Ochoa, J. L. Quiles, J. R. Huertas, and J. Mataix, "Coenzyme Q10 protects from aging-related oxidative stress and improves mitochondrial function in heart of rats fed a polyunsaturated fatty acid (PUFA)-rich diet, " The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, vol. 60, no. 8, pp. 970-975, 2005.
31. S. L. Molyneux, C. M. Florkowski, P. M. George et al., "Coenzyme Q10: An independent predictor of mortality in chronic heart failure, " Journal of theAmericanCollege of Cardiology, vol. 52, no. 18, pp. 1435-1441, 2008.
32. S. A. Mortensen, F. Rosenfeldt, A. Kumar et al., "The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: A randomized double-blind trial, " JACC: Heart Failure, vol. 2, no. 6, pp. 641-649, 2014.
33. M. Bienengraeber, C. Ozcan, and A. Terzic, "Stable transfection of UCP1 confers resistance to hypoxia/reoxygenation in a heartderived cell line, " Journal of Molecular and Cellular Cardiology, vol. 35, no. 7, pp. 861-865, 2003.
34. C. J. McLeod, A. Aziz, R. F. Hoyt Jr., J. P. McCoy Jr., and M. N. Sack, "Uncoupling proteins 2 and 3 function in concert to augment tolerance to cardiac ischemia, "TheJournal of Biological Chemistry, vol. 280, no. 39, pp. 33470-33476, 2005.
35. S. M. Nadtochiy, A. J. Tompkins, and P. S. Brookes, "Different mechanisms of mitochondrial proton leak in ischaemia/reperfusion injury and preconditioning: implications for pathology and cardioprotection, " The Biochemical Journal, vol. 395, no. 3, pp. 611-618, 2006.
36. M. N. Sack, "Mitochondrial depolarization and the role of uncoupling proteins in ischemia tolerance, " Cardiovascular Research, vol. 72, no. 2, pp. 210-219, 2006.
37. C. Ozcan, M. Palmeri, T. L. Horvath, K. S. Russell, and R. R. Russell III, "Role of uncoupling protein 3 in ischemiareperfusion injury, arrhythmias, and preconditioning, " The American Journal of Physiology-Heart and Circulatory Physiology, vol. 304, no. 9, pp. H1192-H1200, 2013.
38. S. Krauss, C.-Y. Zhang, and B. B. Lowell, "The mitochondrial uncoupling-protein homologues, " Nature Reviews Molecular Cell Biology, vol. 6, no. 3, pp. 248-261, 2005.
39. K. S. Echtay, E. Winkler, and M. Klingenberg, "Coenzyme Q is an obligatory cofactor for uncoupling protein function, " Nature, vol. 408, no. 6812, pp. 609-613, 2000.
40. J. Hoerter, M.-D. Gonzalez-Barroso, E. Couplan et al., "Mitochondrial uncoupling protein 1 expressed in the heart of transgenic mice protects against ischemic-reperfusion damage, " Circulation, vol. 110, no. 5, pp. 528-533, 2004.
41. Y. Teshima, M. Akao, S. P. Jones, and E. Marbán, "Uncoupling protein-2 overexpression inhibitsmitochondrial death pathway in cardiomyocytes, " Circulation Research, vol. 93, no. 3, pp. 192-200, 2003.
42. R. J. Youle and A. M. van der Bliek, "Mitochondrial fission, fusion, and stress, " Science, vol. 337, no. 6098, pp. 1062-1065, 2012.
43. M. Liesa, M. Palacín, and A. Zorzano, "Mitochondrial dynamics in mammalian health and disease, " Physiological Reviews, vol. 89, no. 3, pp. 799-845, 2009.
44. T. Koshiba, S. A. Detmer, J. T. Kaiser, H. Chen, J. M. McCaffery, and D. C. Chan, "Structural basis of mitochondrial tethering by mitofusin complexes, " Science, vol. 305, no. 5685, pp. 858-862, 2004.
45. S. Cipolat, O. Martins de Brito, B. Dal Zilio, and L. Scorrano, "OPA1 requires mitofusin 1 to promote mitochondrial fusion, " Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 45, pp. 15927-15932, 2004.
46. E. Smirnova, L. Griparic, D.-L. Shurland, and A. M. van der Bliek, "Dynamin-related protein Drp1 is required formitochondrial division inmammalian cells, "Molecular Biology of the Cell, vol. 12, no. 8, pp. 2245-2256, 2001.
47. Y. Yoon, E. W. Krueger, B. J. Oswald, and M. A. McNiven, "The mitochondrial protein hFis1 regulates mitochondrial fission in mammalian cells through an interaction with the dynamin-like proteinDLP1, "Molecular and Cellular Biology, vol. 23, no. 15, pp. 5409-5420, 2003.
48. P. H. Reddy, "Inhibitors ofmitochondrial fission as a therapeutic strategy for diseases with oxidative stress and mitochondrial dysfunction, " Journal of Alzheimer's Disease, vol. 40, no. 2, pp. 245-256, 2014.
49. W. W. Sharp, Y. H. Fang, M. Han et al., "Dynamin-related protein 1 (Drp1)-mediated diastolic dysfunction in myocardial ischemia-reperfusion injury: Therapeutic benefits of Drp1 inhibition to reduce mitochondrial fission, " The FASEB Journal, vol. 28, no. 1, pp. 316-326, 2014.
50. J. Marín-García, A. T. Akhmedov, and G. W. Moe, "Mitochondria in heart failure: The emerging role of mitochondrial dynamics, " Heart Failure Reviews, vol. 18, no. 4, pp. 439-456, 2013.
51. L. Chen, Q. Gong, J. P. Stice, and A. A. Knowlton, "Mitochondrial OPA1, apoptosis, and heart failure, " Cardiovascular Research, vol. 84, no. 1, pp. 91-99, 2009.
52. S.-B. Ong, S. Subrayan, S. Y. Lim, D. M. Yellon, S. M. Davidson, and D. J. Hausenloy, "Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury, " Circulation, vol. 121, no. 18, pp. 2012-2022, 2010.
53. K. N. Papanicolaou, R. J. Khairallah, G. A. Ngoh et al., "Mitofusin-2 maintains mitochondrial structure and contributes to stress-induced permeability transition in cardiac myocytes, " Molecular and Cellular Biology, vol. 31, no. 6, pp. 1309-1328, 2011.
54. L. Chen, T. Liu, A. Tran et al., "OPA1 mutation and lateonset cardiomyopathy:mitochondrial dysfunction andmtDNA instability, " Journal of the American Heart Association, vol. 1, Article ID e003012, 2012.
55. T. Varanita, M. E. Soriano, V. Romanello et al., "The OPA1-dependent mitochondrial cristae remodeling pathway controls atrophic, apoptotic, and ischemic tissue damage, " Cell Metabolism, vol. 21, no. 6, pp. 834-844, 2015.
56. M. Sumida, K. Doi, E. Ogasawara et al., "Regulation of mitochondrial dynamics by dynamin-related protein-1 in acute cardiorenal syndrome, " Journal of the American Society of Nephrology, vol. 26, no. 10, pp. 2378-2387, 2015.
57. A. Chacinska, C. M. Koehler, D. Milenkovic, T. Lithgow, and N. Pfanner, "Importing mitochondrial proteins: machineries and mechanisms, " Cell, vol. 138, no. 4, pp. 628-644, 2009.
58. O. Schmidt, N. Pfanner, and C. Meisinger, "Mitochondrial protein import: from proteomics to functional mechanisms, " Nature Reviews Molecular Cell Biology, vol. 11, no. 9, pp. 655-667, 2010.
59. J. C. Young, N. J. Hoogenraad, and F. U. Hartl, "Molecular chaperones Hsp90 and Hsp70 deliver preproteins to the mitochondrial import receptor Tom70, " Cell, vol. 112, no. 1, pp. 41-50, 2003.
60. K. Boengler, P. Gres, A. Cabestrero et al., "Prevention of the ischemia-induced decrease in mitochondrial Tom20 content by ischemic preconditioning, " Journal of Molecular and Cellular Cardiology, vol. 41, no. 3, pp. 426-430, 2006.
61. G. Wright, K. Terada, M. Yan, I. Sergeev, and M. Mori, "Oxidative stress inhibits the mitochondrial import of preproteins and leads to their degradation, " Experimental Cell Research, vol. 263, no. 1, pp. 107-117, 2001.
62. J. Li, M. Qi, C. Li et al., "Tom70 serves as a molecular switch to determine pathological cardiac hypertrophy, " Cell Research, vol. 24, no. 8, pp. 977-993, 2014.
63. Z. Yang, W. Sun, and K. Hu, "Molecularmechanismunderlying adenosine receptor-mediated mitochondrial targeting of protein kinase C, " Biochimica et Biophysica Acta (BBA)-Molecular Cell Research, vol. 1823, no. 4, pp. 950-958, 2012.
64. D. J. Hausenloy and D. M. Yellon, "The mitochondrial permeability transition pore: Its fundamental role in mediating cell death during ischaemia and reperfusion, " Journal of Molecular and Cellular Cardiology, vol. 35, no. 4, pp. 339-341, 2003.
65. C. P. Baines, "The molecular composition of the mitochondrial permeability transition pore, " Journal of Molecular and Cellular Cardiology, vol. 46, no. 6, pp. 850-857, 2009.
66. J. Zhu, M. J. Rebecchi, P. S. A. Glass, P. R. Brink, and L. Liu, "Cardioprotection of the aged rat heart by GSK-3 inhibitor is attenuated: Age-related changes in mitochondrial permeability transition pore modulation, " American Journal of Physiology-Heart and Circulatory Physiology, vol. 300, no. 3, pp. H922-H930, 2011.
67. E. N. Dedkova, L. K. Seidlmayer, and L. A. Blatter, "Mitochondria-mediated cardioprotection by trimetazidine in rabbit heart failure, " Journal of Molecular and Cellular Cardiology, vol. 59, pp. 41-54, 2013.
68. P. J. Oliveira, R. Seiça, P. M. Coxito et al., "Enhanced permeability transition explains the reduced calciumuptake in cardiac mitochondria fromstreptozotocin-induced diabetic rats, " FEBS Letters, vol. 554, no. 3, pp. 511-514, 2003.
69. D. J. Hausenloy, M. R. Duchen, and D. M. Yellon, "Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury, " Cardiovascular Research, vol. 60, no. 3, pp. 617-625, 2003.
70. M. Saotome, H. Katoh, Y. Yaguchi et al., "Transient opening of mitochondrial permeability transition pore by reactive oxygen species protects myocardium from ischemia-reperfusion injury, " American Journal of Physiology-Heart and Circulatory Physiology, vol. 296, no. 4, pp. H1125-H1132, 2009.
71. M. J. Berridge, P. Lipp, and M. D. Bootman, "The versatility and universality of calcium signalling, " Nature Reviews Molecular Cell Biology, vol. 1, no. 1, pp. 11-21, 2000.
72. A. B. Aurora, A. I. Mahmoud, X. Luoet al., "MicroRNA-214protects the mouse heart from ischemic injury by controlling Ca2+ overload and cell death, " The Journal of Clinical Investigation, vol. 122, no. 4, pp. 1222-1232, 2012.
73. T. Liu, E. Takimoto, V. L. Dimaano et al., "InhibitingmitochondrialNa +/Ca2+ exchange prevents sudden death in a Guinea pig model of heart failure, " Circulation Research, vol. 115, no. 1, pp. 44-54, 2014.
74. P. S. Brookes, Y. Yoon, J. L. Robotham, M. W. Anders, and S.-S. Sheu, "Calcium, ATP, and ROS: A mitochondrial love-hate triangle, " American Journal of Physiology-Cell Physiology, vol. 287, no. 4, pp. C817-C833, 2004.
75. M. Aldakkak, A. K. S. Camara, J. S. Heisner, M. Yang, and D. F. Stowe, "Ranolazine reduces Ca2+ overload and oxidative stress and improves mitochondrial integrity to protect against ischemia reperfusion injury in isolated hearts, " Pharmacological Research, vol. 64, no. 4, pp. 381-392, 2011.
76. M. L. Riess, A. K. S. Camara, L. G. Kevin, J. An, and D. F. Stowe, "Reduced reactive O2 species formation and preserved mitochondrial NADH and [Ca2+] levels during short-term 17 c ischemia in intact hearts, " Cardiovascular Research, vol. 61, no. 3, pp. 580-590, 2004.
77. M. L. Riess, A. K. S. Camara, E. Novalija, Q. Chen, S. S. Rhodes, and D. F. Stowe, "Anesthetic preconditioning attenuates mitochondrial Ca2+ overload during ischemia in Guinea pig intact hearts: reversal by 5-hydroxydecanoic acid, " Anesthesia and Analgesia, vol. 95, no. 6, pp. 1540-1546, 2002.
78. R. Ferrari, P. Pedersini, M. Bongrazio et al., "Mitochondrial energy production and cation control in myocardial ischaemia and reperfusion, " Basic Research in Cardiology, vol. 88, no. 5, pp. 495-512, 1993.
79. D. De Stefani, A. Raffaello, E. Teardo, I. Szabó, and R. Rizzuto, "A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter, " Nature, vol. 476, no. 7360, pp. 336-340, 2011.
80. D. De Stefani, M. Patron, and R. Rizzuto, "Structure and function of the mitochondrial calcium uniporter complex, " Biochimica et Biophysica Acta (BBA)-Molecular Cell Research, vol. 1853, no. 9, pp. 2006-2011, 2015.
81. T. M. Ye, S. Z. Zhang, and Q. Xia, "Role of mitochondrial calcium uniporter in myocardial hypoxia/reoxygenation induced injury, " Chinese Journal of Applied Physiology, vol. 22, pp. 136-140, 2006.
82. M. Ahuja and S. Muallem, "The gatekeepers of mitochondrial calciuminflux:MICU1 andMICU2, " EMBO Reports, vol. 15, no. 3, pp. 205-206, 2014.
83. K. J. Kamer and V. K. Mootha, "MICU1 and MICU2 play nonredundant roles in the regulation of the mitochondrial calcium uniporter, " EMBO Reports, vol. 15, no. 3, pp. 299-307, 2014.
84. K. Mallilankaraman, P. Doonan, C. Cárdenas et al., "MICU1 is an essential gatekeeper for mcu-mediated mitochondrial Ca2+ uptake that regulates cell survival, " Cell, vol. 151, no. 3, pp. 630-644, 2012.
85. M. Patron, V. Checchetto, A. Raffaello et al., "MICU1 and MICU2 finely tune the mitochondrial Ca2+ uniporter by exerting opposite effects onMCUactivity, "Molecular Cell, vol. 53, no. 5, pp. 726-737, 2014.
86. W. Wang, Q. Xie, X. Zhou et al., "Mitofusin-2 triggers mitochondria Ca2+ influx from the endoplasmic reticulum to induce apoptosis in hepatocellular carcinoma cells, " Cancer Letters, vol. 358, no. 1, pp. 47-58, 2015.
87. P. Michela, V. Velia, P. Aldo, and P. Ada, "Role of connexin 43 in cardiovascular diseases, " European Journal of Pharmacology, vol. 768, pp. 71-76, 2015.
88. A. Rodriguez-Sinovas, K. Boengler, A. Cabestrero et al., "Translocation of connexin 43 to the inner mitochondrial membrane of cardiomyocytes through the heat shock protein 90-dependent TOMpathway and its importance for cardioprotection, " Circulation Research, vol. 99, no. 1, pp. 93-101, 2006.
89. K.-G. Shyu, B.-W. Wang, W.-P. Cheng, and H.-M. Lo, "MicroRNA-208a increases myocardial endoglin expression and myocardial fibrosis in acute myocardial infarction, " Canadian Journal of Cardiology, vol. 31, no. 5, pp. 679-690, 2015.
90. R. Schulz, P. M. Görge, A. Görbe, P. Ferdinandy, P. D. Lampe, and L. Leybaert, "Connexin 43 is an emerging therapeutic target in ischemia/reperfusion injury, cardioprotection and neuroprotection, " Pharmacology & Therapeutics, vol. 153, pp. 90-106, 2015.
91. N. Wang, E. De Vuyst, R. Ponsaerts et al., "Selective inhibition of Cx43 hemichannels by Gap19 and its impact on myocardial ischemia/reperfusion injury, " Basic Research in Cardiology, vol. 108, article 309, 2013.
92. G. Chen, J. Zhao, C. Liu, Y. Zhang, Y. Huo, and L. Zhou, "MG132 proteasome inhibitor upregulates the expression of connexin 43 in rats with adriamycin-induced heart failure, " Molecular Medicine Reports, vol. 12, no. 5, pp. 7595-7602, 2015.
93. G. Heusch, J. Musiolik, N. Gedik, and A. Skyschally, "Mitochondrial STAT3 activation and cardioprotection by ischemic postconditioning in pigs with regional myocardial ischemia/reperfusion, " Circulation Research, vol. 109, no. 11, pp. 1302-1308, 2011.
94. K. Szczepanek, E. J. Lesnefsky, and A. C. Larner, "Multitasking: nuclear transcription factors with novel roles in the mitochondria, " Trends in Cell Biology, vol. 22, no. 8, pp. 429-437, 2012.
95. F. A. Zouein, R. Altara, Q. Chen, E. J. Lesnefsky, M. Kurdi, and G. W. Booz, "Pivotal importance of STAT3 in protecting the heart from acute and chronic stress: new advancement and unresolved issues, " Frontiers in Cardiovascular Medicine, vol. 2, article 36, 2015.
96. K. Szczepanek, Q. Chen, A. C. Larner, and E. J. Lesnefsky, "Cytoprotection by the modulation of mitochondrial electron transport chain: The emerging role of mitochondrial STAT3, " Mitochondrion, vol. 12, no. 2, pp. 180-189, 2012.
97. J. Wegrzyn, R. Potla, Y.-J. Chwae et al., "Function of mitochondrial Stat3 in cellular respiration, " Science, vol. 323, no. 5915, pp. 793-797, 2009.
98. K. Szczepanek, Q. Chen, M. Derecka et al., "Mitochondrialtargeted signal transducer and activator of transcription 3 (STAT3) protects against ischemia-induced changes in the electron transport chain and the generation of reactive oxygen species, " The Journal of Biological Chemistry, vol. 286, no. 34, pp. 29610-29620, 2011.